UK Companies House feature
MERCURY PHARMACEUTICALS LIMITED
Profile
- Company number
- 02619880
- Status
- Active
- Incorporation
- 1991-06-12
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In assessing the ability of the Company to continue as a going concern, the directors have taken account of the profit in 2024 of £3,017, the cumulative profits of £26,838, and the Company's net current assets and net asset position of £27,569 at 31 December 2024. The Company's Intermediate Holding Company, APHL has provided the Company with a letter of support indicating its intention to provide the financial support required for a period of at least 12 months from the date these financial statements are approved... Accordingly, the directors consider it appropriate to prepare these entity financial statements on a going concern basis.”
Subsidiaries
- Amdipharm Mercury (Australia) Pty Limited · 1% held · Australia
Significant events
- “In 2023, the Group has conducted its first materiality assessment and reshaped its ESG roadmap. During 2024, the Group conducted a double materiality assessment exercise in accordance with the European Union's Corporate Sustainability Reporting Directive ("CSRD").”
- “On 25 October 2024, the Group, through its wholly owned subsidiary Cidron Aida Finco SaRL, entered into a senior facilities agreement pursuant to which a syndicate of lenders made available a secured term loan at par for the principal amount of €725 million.”
- “On 10 October 2016, the UK Competition and Markets Authority ("CMA") commenced an investigation into ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA") in relation to the pricing of liothyronine tablets in the UK...On 8 May 2025, the Court of Appeal issued its judgment in which it upheld the CMA's findings against the Company and the Group. On 5 June 2025 the Company and the Group filed an application with the Court of Appeal seeking permission to appeal.”
- “On 8 April 2025, the Group successfully completed the refinancing of its existing €650 million 5% senior secured notes due 2028 and £335 million 6.25% senior secured notes due 2028. This refinancing was effected through the issuance of €615 million in 7% senior secured notes due 2031 and £250 million in 9.125% senior secured notes due 2031, together with a new €165 million term loan facility.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 25 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| TMF CORPORATE ADMINISTRATION SERVICES LIMITED | Corporate Secretary | 2022-03-16 | — | — |
| FERRY, Melvin Jeremy, Mr. | Director | 2025-02-06 | Jun 1982 | British |
| STICKLER, Andreas | Director | 2022-01-21 | Feb 1971 | German |
Show 25 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FARLEY, Joseph | Secretary | 1995-07-11 | 2004-12-03 |
| PATEL, Hitesh Dinubha | Secretary | 1993-06-18 | 1994-06-07 |
| PATEL, Kirti Vinubhai | Secretary | 1994-06-07 | 1995-07-11 |
| PATEL, Kirti Vinubhai | Secretary | — | 1993-06-18 |
| SULLY, Robert | Secretary | 2018-10-01 | 2022-03-16 |
| SULLY, Robert James | Secretary | 2011-07-25 | 2016-12-31 |
| VENKATESWARAN, Subramanian | Secretary | 2004-12-03 | 2011-06-24 |
| WILLIAMS, David Richard | Secretary | 2016-12-31 | 2018-10-01 |
| AHMAD, Adeel | Director | 2016-01-08 | 2022-01-31 |
| BALMER, Paul Duncan | Director | 1993-06-18 | 1994-01-17 |
| BEIGHTON, John | Director | 2010-09-08 | 2016-12-31 |
| DUNCAN, Graeme Neville | Director | 2018-11-30 | 2022-01-12 |
| DUNCAN, Graeme Neville | Director | 2016-12-31 | 2018-03-08 |
| GOGERLY, Robert Shane | Director | — | 1992-10-01 |
| KAMATH, Vikram Laxman | Director | 2012-10-23 | 2025-02-06 |
| PATEL, Ajay Mafatlal | Director | 2000-01-04 | 2010-08-31 |
| PATEL, Ajit Ramanlal | Director | — | 2007-07-02 |
| PATEL, Kirti Vinubhai | Director | 1996-03-25 | 2007-12-31 |
| PATEL, Mukesh Kanubhai | Director | 1992-10-23 | 1998-05-12 |
| PATEL, Rakesh Vinodrai | Director | 2000-01-04 | 2010-05-19 |
| RAMAN, Anand | Director | 2011-01-26 | 2012-10-23 |
| REARDON, Michael John | Director | 2005-10-01 | 2007-11-14 |
| SCHWALBER, Philipp Theodor | Director | 2010-03-02 | 2012-04-18 |
| STONE, Lisa | Director | 2010-03-02 | 2012-04-18 |
| VAN TIGGELEN, Antonie Pieter | Director | 2013-09-25 | 2016-01-08 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mercury Pharma Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-06-01 | Active |
| The Blackstone Group Inc. | Corporate entity | Shares 25–50%, Voting 25–50% | 2020-03-27 | Ceased 2021-06-01 |
| Mercury Pharma Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2018-08-10 | Ceased 2020-03-27 |
Filing timeline
Last 20 of 200 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-10-07 | AA | accounts | accounts with accounts type full |
| 2025-07-21 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-02-20 | AP01 | officers | appoint person director company with name date |
| 2025-02-19 | TM01 | officers | termination director company with name termination date |
| 2024-09-02 | AA | accounts | accounts with accounts type full |
| 2024-07-31 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-03-14 | AA | accounts | accounts with accounts type full |
| 2023-08-17 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2023-08-02 | CH01 | officers | change person director company with change date |
| 2023-08-01 | AD01 | address | change registered office address company with date old address new address |
| 2023-07-26 | CH04 | officers | change corporate secretary company with change date |
| 2023-07-26 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-07-21 | CH01 | officers | change person director company with change date |
| 2022-09-30 | AA | accounts | accounts with accounts type full |
| 2022-07-21 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-03-28 | AP04 | officers | appoint corporate secretary company with name date |
| 2022-03-28 | TM02 | officers | termination secretary company with name termination date |
| 2022-02-02 | AP01 | officers | appoint person director company with name date |
| 2022-02-01 | TM01 | officers | termination director company with name termination date |
| 2022-01-26 | TM01 | officers | termination director company with name termination date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.